EAPIF Financials: Euroapi S.A. AI Analysis



Financials

EAPIF Financial

Euroapi S.A.

$1.51

At close: Jun 18, 16:00:00 GMT-4

$1.51

Post-market: Jun 18, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$1.51

Open

$1.71

Day's Range

$1.51 - $1.71

52 week range

$1.27 - $3.74

Volume

100

Avg.Volume

168

Dividend yield

EPS (TTM)

-2.59

Market Cap

$143.7M

What is EUROAPI SA?

EUROAPI SA engages in manufacturing and supply of active pharmaceutical ingredient solutions for healthcare companies. The company employs 3,133 full-time employees The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.

Features

Markets

News

Breakdown	TTM	12/31/2025	06/30/2025	12/31/2024	06/30/2024	12/31/2023
Revenue	852	438	414	468	450	520
Revenue Growth (YoY)	-7%	-6%	-8%	-10%	-10%	5%
Cost of Revenue	707	369	337	423	352	453
Gross Profit	144	68	76	44	98	67
Selling, General & Admin	115	59	56	61	65	67
Research & Development	27	17	10	11	13	16
Operating Expenses	141	75	65	73	77	84
Other Non Operating Income (Expenses)	-4	-2	-2	-7	-9	-4
Pretax Income	-138	-108	-30	-98	-41	-255
Income Tax Expense	72	74	-1	-2	-6	-2
Net Income	-211	-182	-28	-95	-34	-253
Net Income Growth	62%	92%	-18%	-62%	-155%	716%
Shares Outstanding (Diluted)	94.8	94.8	94.6	94.7	94.3	95
Shares Change (YoY)	0%	0%	0%	0%	-1%	0%
EPS (Diluted)	-2.22	-1.92	-0.3	-1.01	-0.36	-2.67
EPS Growth	61%	91%	-18%	-62%	-156%	685%
Free Cash Flow	50	69	-19	4	10	-16
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	16.9%	15.52%	18.35%	9.4%	21.77%	12.88%
Operating Margin	0.35%	-1.59%	2.41%	-5.98%	4.44%	-3.07%
Profit Margin	-24.76%	-41.55%	-6.76%	-20.29%	-7.55%	-48.65%
Free Cash Flow Margin	5.86%	15.75%	-4.58%	0.85%	2.22%	-3.07%
EBITDA	143	100	42	16	52	250
EBITDA Margin	16.78%	22.83%	10.14%	3.41%	11.55%	48.07%
D&A For EBITDA	140	107	32	44	32	266
EBIT	3	-7	10	-28	20	-16
EBIT Margin	0.35%	-1.59%	2.41%	-5.98%	4.44%	-3.07%
Effective Tax Rate	-52.17%	-68.51%	3.33%	2.04%	14.63%	0.78%

Breakdown

TTM

12/31/2025

06/30/2025

12/31/2024

06/30/2024

12/31/2023

Revenue

852

438

414

468

450

520

Revenue Growth (YoY)

-7%

-6%

-8%

-10%

Cost of Revenue

707

369

337

423

352

453

Gross Profit

144

Selling, General & Admin

115

Research & Development

Operating Expenses

141

Other Non Operating Income (Expenses)

-4

-2

-7

-9

-4

Pretax Income

-138

-108

-30

-98

-41

-255

Income Tax Expense

-1

-2

-6

-2

Net Income

-211

-182

-28

-95

-34

-253

Net Income Growth

62%

92%

-18%

-62%

-155%

716%

Shares Outstanding (Diluted)

94.8

94.6

94.7

94.3

Shares Change (YoY)

-1%

EPS (Diluted)

-2.22

-1.92

-0.3

-1.01

-0.36

-2.67

EPS Growth

61%

91%

-18%

-62%

-156%

685%

Free Cash Flow

-19

-16

Free Cash Flow Per Share

Gross Margin

16.9%

15.52%

18.35%

9.4%

21.77%

12.88%

Operating Margin

0.35%

-1.59%

2.41%

-5.98%

4.44%

-3.07%

Profit Margin

-24.76%

-41.55%

-6.76%

-20.29%

-7.55%

-48.65%

Free Cash Flow Margin

5.86%

15.75%

-4.58%

0.85%

2.22%

-3.07%

EBITDA

143

100

250

EBITDA Margin

16.78%

22.83%

10.14%

3.41%

11.55%

48.07%

D&A For EBITDA

140

107

266

EBIT

-7

-28

-16

EBIT Margin

0.35%

-1.59%

2.41%

-5.98%

4.44%

-3.07%

Effective Tax Rate

-52.17%

-68.51%

3.33%

2.04%

14.63%

0.78%

Follow-Up Questions

What are Euroapi S.A.'s key financial statements?



According to the latest financial statement (Form-10K), Euroapi S.A. has a total asset of $0, Net loss of $0

What are the key financial ratios for EAPIF?



Euroapi S.A.'s Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Euroapi S.A.'s revenue broken down by segment or geography?



Euroapi S.A. largest revenue segment is Complex Chemical Synthesis Molecules, at a revenue of 587,900,000 in the most earnings release.For geography, Europe is the primary market for Euroapi S.A., at a revenue of 568,200,000.

Is Euroapi S.A. profitable?



no, according to the latest financial statements, Euroapi S.A. has a net loss of $0

Does Euroapi S.A. have any liabilities?



no, Euroapi S.A. has liability of 0

How many outstanding shares for Euroapi S.A.?



Euroapi S.A. has a total outstanding shares of 0

Euroapi S.A. (EAPIF) Financial

EAPIF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is EUROAPI SA?

Euroapi S.A. (EAPIF) Financial

EAPIF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is EUROAPI SA?

EAPIF Income

Follow-Up Questions

What are Euroapi S.A.'s key financial statements?

What are the key financial ratios for EAPIF?

How is Euroapi S.A.'s revenue broken down by segment or geography?

Is Euroapi S.A. profitable?

Does Euroapi S.A. have any liabilities?

How many outstanding shares for Euroapi S.A.?